Modulation of the Tumor Suppressor Protein α-Catenin by Ischemic Microenvironment
Claire Plumb(University of Guelph), Brenda L. Coomber(University of Guelph)
Cited by 8
Related Papers
VEGFR2 heterogeneity and response to anti-angiogenic low dose metronomic cyclophosphamide treatment
|BMC Cancer|2010|33
Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells
|Laboratory Investigation|2010|30
Lack of Efficacy of Combined Antiangiogenic Therapies in Xenografted Human Melanoma
|Journal of Oncology|2011|0